The European Commission announced this Friday that it has signed two deals with pharmaceutical companies AstraZeneca and Johnson Johnson to purchase a total of 500 million doses of the future coronavirus vaccine.
As reported by Brussels, the agreement with AstraZeneca includes 300 million cans with the option to purchase another 100 million on behalf of the countries of the European bloc. While the Johnson Johnson contract includes 200 million doses and the option to purchase an additional 200, a portion of these vaccines will be donated to low and middle income countries and redistributed through the Foreign Action Service.
At a press conference, a spokeswoman for the European executive avoided giving details of the cost of the contract, despite assuring that she was meeting the financial obligations laid down by Community law.
For the President of the Commission, Ursula von der Leyen, this agreement is the result of intensive negotiations and she has estimated that it is “the first stone in launching the Commission’s strategy on vaccines” that will enable Creating future vaccines for European citizens as well as for the partners of the Union.